U.S. Markets closed
  • S&P Futures

    3,787.00
    -29.75 (-0.78%)
     
  • Dow Futures

    31,060.00
    -176.00 (-0.56%)
     
  • Nasdaq Futures

    12,546.75
    -135.00 (-1.06%)
     
  • Russell 2000 Futures

    2,182.70
    -23.10 (-1.05%)
     
  • Crude Oil

    61.76
    +0.48 (+0.78%)
     
  • Gold

    1,711.00
    -4.80 (-0.28%)
     
  • Silver

    26.17
    -0.21 (-0.80%)
     
  • EUR/USD

    1.2055
    -0.0012 (-0.0964%)
     
  • 10-Yr Bond

    1.4700
    +0.0550 (+3.89%)
     
  • Vix

    26.67
    +2.57 (+10.66%)
     
  • GBP/USD

    1.3946
    -0.0007 (-0.0502%)
     
  • USD/JPY

    107.0310
    +0.0290 (+0.0271%)
     
  • BTC-USD

    49,747.37
    +931.98 (+1.91%)
     
  • CMC Crypto 200

    993.47
    +5.38 (+0.54%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    28,734.58
    -824.52 (-2.79%)
     

Company News for Dec 13, 2019

Zacks Equity Research
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Shares of Facebook, Inc. FB dropped 2.7% after reports flashed that FTC is considering seeking a preliminary injunction over antitrust concerns related to how its products interact

  • Shares of Amneal Pharmaceuticals, Inc. AMRX jumped 44.8% after the company announced that FDA has approved the abbreviated new drug application for EluRyng

  • Shares of LMP Automotive Holdings, Inc. LMPX soared 44.7% after the company’s President and CEO, Samer Tawfik, purchased $1.73 million of the company's shares

  • Shares of Tonix Pharmaceuticals Holding Corp. TNXP rose 22.7% after the company announced a new European patent for composition and formulation of TNX-102 SL


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Facebook, Inc. (FB) : Free Stock Analysis Report
 
AMNEAL PHARMACEUTICALS, INC. (AMRX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research